|
July 10, 2005
Elusys
An article by Ron Bailey at Reason brought Elusys to my attention a few years back. They were a biotech research company with a novel idea. On a whim, I checked out their website the other day to see how they were progressing. Huh. Things are just perking along. This news release was from late 2003. There's more if you care to look. Elusys Therapeutics, Inc., today released data showing that its anthrax antibody, ETI-204, provided complete protection in animals that were exposed to aerosolized anthrax, the form most likely to be used in a terrorist attack. None of the animals given the affinity-enhanced antibody died in the 28-day study, which ended today, while all of the control animals died within 5 days. Nice work. posted by Justin on 07.10.05 at 01:42 AM |
|
March 2007
WORLD-WIDE CALENDAR
Search the Site
E-mail
Classics To Go
Archives
March 2007
February 2007 January 2007 December 2006 November 2006 October 2006 September 2006 August 2006 July 2006 June 2006 May 2006 April 2006 March 2006 February 2006 January 2006 December 2005 November 2005 October 2005 September 2005 August 2005 July 2005 June 2005 May 2005 April 2005 March 2005 February 2005 January 2005 December 2004 November 2004 October 2004 September 2004 August 2004 July 2004 June 2004 May 2004 April 2004 March 2004 February 2004 January 2004 December 2003 November 2003 October 2003 September 2003 August 2003 July 2003 June 2003 May 2003 May 2002 See more archives here Old (Blogspot) archives
Recent Entries
War For Profit
How trying to prevent genocide becomes genocide I Have Not Yet Begun To Fight Wind Boom Isaiah Washington, victim Hippie Shirts A cunning exercise in liberation linguistics? Sometimes unprincipled demagogues are better than principled activists PETA agrees -- with me! The high pitched squeal of small carbon footprints
Links
Site Credits
|
|